U.S. markets closed
  • S&P 500

    4,662.85
    +3.82 (+0.08%)
     
  • Dow 30

    35,911.81
    -201.79 (-0.56%)
     
  • Nasdaq

    14,893.75
    +86.95 (+0.59%)
     
  • Russell 2000

    2,162.46
    +3.02 (+0.14%)
     
  • Crude Oil

    84.27
    +0.45 (+0.54%)
     
  • Gold

    1,817.30
    +0.80 (+0.04%)
     
  • Silver

    22.99
    +0.07 (+0.31%)
     
  • EUR/USD

    1.1413
    -0.0047 (-0.41%)
     
  • 10-Yr Bond

    1.7720
    +0.0610 (+3.57%)
     
  • GBP/USD

    1.3671
    -0.0039 (-0.29%)
     
  • USD/JPY

    114.2990
    +0.1190 (+0.10%)
     
  • BTC-USD

    43,212.76
    -54.04 (-0.12%)
     
  • CMC Crypto 200

    1,037.76
    +12.03 (+1.17%)
     
  • FTSE 100

    7,542.95
    -20.90 (-0.28%)
     
  • Nikkei 225

    28,124.28
    -364.82 (-1.28%)
     

Alimera Sciences to Participate in Upcoming November 2021 Investor Conferences

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

ATLANTA, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces that Rick Eiswirth, Alimera’s President and Chief Executive Officer, will participate in three investor conference events in November.

Mr. Eiswirth will be presenting at the Q4 Investor Summit Conference, November 16-17, 2021, at 9:30 AM ET and will be available for one-on-one meetings throughout the conference.

Additionally, he will be participating in one-on-one and small group meetings via video conference at Alliance Global Partners Virtual Biotech & Specialty Pharma Conference, November 10, 2021 and the 12th Annual Craig-Hallum Alpha Select Conference, November 16, 2021.

About Alimera Sciences, Inc.

Alimera Sciences a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer. For more information, please visit www.alimerasciences.com.

For press inquiries:
Jules Abraham
for Alimera Sciences
917-885-7378
julesa@coreir.com

For investor inquiries:
Scott Gordon
for Alimera Sciences
scottg@coreir.com